Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12960835rdf:typepubmed:Citationlld:pubmed
pubmed-article:12960835lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C0559522lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C1185740lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C1510802lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C1441672lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C1963724lld:lifeskim
pubmed-article:12960835lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:12960835pubmed:issue13lld:pubmed
pubmed-article:12960835pubmed:dateCreated2003-9-8lld:pubmed
pubmed-article:12960835pubmed:abstractTextSix women with substance abuse and poor adherence histories received daily antiretroviral directly observed therapy (DOT). Cervicovaginal lavage (CVL) and plasma HIV-1-RNA levels were measured at baseline, 1 month, 3 months, and 6 months. All subjects had undetectable (below 2.6 log10 copies/ml) CVL HIV-1-RNA levels by 3 months and undetectable plasma HIV-1-RNA levels by 6 months. The mean CD4 cell increase was 76 cells/mm3. DOT appears effective and may reduce infectiousness in this high-risk population.lld:pubmed
pubmed-article:12960835pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:languageenglld:pubmed
pubmed-article:12960835pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:citationSubsetIMlld:pubmed
pubmed-article:12960835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12960835pubmed:statusMEDLINElld:pubmed
pubmed-article:12960835pubmed:monthSeplld:pubmed
pubmed-article:12960835pubmed:issn0269-9370lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:CaliendoAngel...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:Cu-UvinSusanSlld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:FlaniganTimot...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:CarpenterChar...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:MacalinoGrace...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:HarwellJoseph...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:MittyJennifer...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:IngersollJess...lld:pubmed
pubmed-article:12960835pubmed:authorpubmed-author:StenzelMolly...lld:pubmed
pubmed-article:12960835pubmed:issnTypePrintlld:pubmed
pubmed-article:12960835pubmed:day5lld:pubmed
pubmed-article:12960835pubmed:volume17lld:pubmed
pubmed-article:12960835pubmed:ownerNLMlld:pubmed
pubmed-article:12960835pubmed:authorsCompleteYlld:pubmed
pubmed-article:12960835pubmed:pagination1990-3lld:pubmed
pubmed-article:12960835pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:meshHeadingpubmed-meshheading:12960835...lld:pubmed
pubmed-article:12960835pubmed:year2003lld:pubmed
pubmed-article:12960835pubmed:articleTitleDirectly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence.lld:pubmed
pubmed-article:12960835pubmed:affiliationBrown University, Providence, RI, USA.lld:pubmed
pubmed-article:12960835pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12960835pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12960835lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12960835lld:pubmed